|Articles|July 1, 2015
Addressing Drug Quality: Aging Facilities
Sue Schniepp, Chair, PDA Regulatory and Quality Advisory Board, and Hal Basemen, Chair, PDA, speak with BioPharm International.
Advertisement
Sue Schniepp, Chair, PDA Regulatory and Quality Advisory Board, and Hal Basemen, Chair, PDA, spoke with BioPharm International about addressing drug quality in aging facilities.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Agenus Closes $141 Million Immunotherapy Collaboration with Zydus Lifesciences
2
Beyond Transactional: Collaborative Partnerships for Rapid, Flexible Biologics Development
3
Novartis Calls for Global Governments to Address Global Trade Policy
4
EC’s High-Dose Aflibercept Approval Highlights Durable Anti-VEGF Retinal Therapy
5